TTK/hMPS1 Is an Attractive Therapeutic Target for Triple-Negative Breast Cancer

• Virginie Maire,

  Affiliations Institut Curie, Research Center, Paris, France, Breast Cancer Biology Group, Department of Translational Research, Paris, France

  ⨯
• Céline Baldeyron,

  Affiliations Institut Curie, Research Center, Paris, France, Breast Cancer Biology Group, Department of Translational Research, Paris, France

  ⨯
• Marion Richardson,

  Affiliations Institut Curie, Research Center, Paris, France, Tumor Biology, Service of Pathology, Paris, France

  ⨯
• Bruno Tesson,

  Affiliations Institut Curie, Research Center, Paris, France, Breast Cancer Biology Group, Department of Translational Research, Paris, France, INSERM U900, Bioinformatics, Biostatistics, Epidemiology and Computational Systems Biology of Cancer, Paris, France, Mines ParisTech, Fontainebleau, France

  ⨯
• Anne Vincent-Salomon,

  Affiliations Institut Curie, Research Center, Paris, France, Tumor Biology, Service of Pathology, Paris, France

  ⨯
• Eléonore Gravier,

  Affiliations Institut Curie, Research Center, Paris, France, INSERM U900, Bioinformatics, Biostatistics, Epidemiology and Computational Systems Biology of Cancer, Paris, France, Mines ParisTech, Fontainebleau, France

  ⨯
• Bérengère Marty-Prouvost,

  Affiliations Institut Curie, Research Center, Paris, France, Breast Cancer Biology Group, Department of Translational Research, Paris, France

  ⨯
• Leanne De Koning,

  Affiliations Institut Curie, Research Center, Paris, France, RPPA platform, Department of Translational Research, Paris, France

  ⨯
• Guillem Rigaill,

  Affiliations Institut Curie, Research Center, Paris, France, Breast Cancer Biology Group, Department of Translational Research, Paris, France, INSERM U900, Bioinformatics, Biostatistics, Epidemiology and Computational Systems Biology of Cancer, Paris, France, Mines ParisTech, Fontainebleau, France, AgroParisTech/INRA, UMR 518, MIA, Paris, France

  ⨯
• Aurélie Dumont,

  Affiliations Institut Curie, Research Center, Paris, France, Breast Cancer Biology Group, Department of Translational Research, Paris, France

  ⨯
• David Gentien,

  Affiliations Institut Curie, Research Center, Paris, France, Platform of Molecular Biology Facilities, Department of Translational Research, Paris, France

  ⨯
• Emmanuel Barillot,

  Affiliations Institut Curie, Research Center, Paris, France, INSERM U900, Bioinformatics, Biostatistics, Epidemiology and Computational Systems Biology of Cancer, Paris, France, Mines ParisTech, Fontainebleau, France

  ⨯
• Sergio Roman-Roman,

  Affiliations Institut Curie, Research Center, Paris, France, Breast Cancer Biology Group, Department of Translational Research, Paris, France

  ⨯
• Stéphane Depil,

  Affiliation Oncology Research and Development Unit, Institut de Recherches SERVIER, Croissy-sur-Seine, France

  ⨯
• Francisco Cruzalegui,

  Affiliation Oncology Research and Development Unit, Institut de Recherches SERVIER, Croissy-sur-Seine, France

  ⨯
• Alain Pierré,

  Affiliation Oncology Research and Development Unit, Institut de Recherches SERVIER, Croissy-sur-Seine, France

  ⨯
• Gordon C. Tucker,

  Affiliation Oncology Research and Development Unit, Institut de Recherches SERVIER, Croissy-sur-Seine, France

  ⨯
•  [ ... ],
• Thierry Dubois

  * E-mail: thierry.dubois@curie.fr

  Affiliations Institut Curie, Research Center, Paris, France, Breast Cancer Biology Group, Department of Translational Research, Paris, France

  ⨯
• [ view all ]
• [ view less ]